News & Events

• March 19, 2013
  

  Opportunities and Challenges of Safety Biomarker Qualification: Perspectives from the Predictive Safety Testing Consortium

  Dennis E.H., Walker E.G., Baker A.F., Miller R.T. (2013) Opportunities and Challenges of Safety Biomarker Qualification: Perspectives from the Predictive Safety Testing Consortium. Drug Development Research Special Issue: Biomarkers in Drug Development and Companion Diagnostics 74(2):112-26.

• March 16, 2013
  

  Development of a patient-reported outcome (PRO) instrument to assess complex activities of daily living and interpersonal functioning in patients with mild cognitive impairment due to suspected Alzheimer’s disease: the qualitative research phase

• March 15, 2013
  

  The Coalition Against Major Diseases: Dopamine Transmitter Neuroimaging as an Enrichment Biomarker to Enable Parkinson’s Disease Clinical Trials

• March 13, 2013
  

  Advancing Adoption of Novel Safety Biomarkers into Drug Development through Voluntary Submission of Data at US FDA, EMA, and PMDA

  Presenter – E Gribble Walker, M Brumfield, E H Dennis Conference – Society of Toxicologists 2013 Annual Meeting PDF Presentation.
• March 13, 2013
  

  Evaluation of Novel Biomarkers of Nephrotoxicity in Monkeys Treated with Gentamicin

  Presenter РJ Gautier, X Zhou, Y Yang, T Gury, Z Qu, J L̩onard, J Wang, P Detilleux, B Li Conference РSociety of Toxicologists 2013 Annual Meeting